Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates
Amount Raised
€10 Million
Round Type
Series A
MunichBiotechnologyHealth CareDescription
Tubulis today announced the close of a €10.7 million Series A financing round to accelerate the development of a new class of highly stable and efficient antibody-drug conjugates (ADCs) and to support the further growth of the company. The financing round was co-led by BioMedPartners and High-Tech Gründerfonds (HTGF) with support from Seventure Partners, coparion, Bayern Kapital, and OCCIDENT alongside significant contributions by high net worth individuals and the founders. Tubulis was spun out in 2019 from the Leibniz Research Institute in Berlin (FMP) and the Ludwig Maximilians University (LMU) in Munich with the aim of expanding the therapeutic potential of ADCs for cancer and other disease indications.
Quick answer
Tubulis raised €10 Million in a Series A round, dated July 21, 2020. Tubulis is based in Munich, Bavaria, Germany.
- How much did Tubulis raise?
- Tubulis raised €10 Million in a Series A round on July 21, 2020.
- What does Tubulis do?
- Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.
- Where is Tubulis based and how big is it?
- Tubulis is based in Munich, Bavaria, Germany. Fundz records about 73 employees.
- Who are the decision-makers at Tubulis?
- Fundz holds 1 contact at Tubulis. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Tubulis that raised within 45 days of this round, from Fundz verified event records.
- Monteris Medical raised $9M on September 4, 2020.
- Escient Pharmaceuticals raised $33M on September 4, 2020.
- Endovia Health Sciences, Inc. raised $1.2M on September 2, 2020.
- ORTHALIGN INC raised $11M on September 2, 2020.
- Adipo Therapeutics raised $1.3M (Seed) on September 2, 2020.
- Helus Pharma raised an undisclosed amount on September 1, 2020.
Who to call at Tubulis, and when
A new round usually means Tubulis is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tubulis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tubulis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tubulis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tubulis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTubulis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.